Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B
about
Epidemiology and Diagnosis of Hypoparathyroidism.Renal phosphate wasting in the absence of adenylyl cyclase 6An update on the clinical and molecular characteristics of pseudohypoparathyroidism.Pharmacokinetics in rats of a long-acting human parathyroid hormone-collagen binding domain peptide construct.Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone.Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b.
P2860
Q33570602-7229342C-C8C1-44A4-9811-E3E2292066FCQ34568797-EBB14AC5-4ADF-4B01-8131-D599FD735D6FQ36921018-ADA0B17C-0955-4BFD-8516-2D31EA7A51B9Q37727097-8F7E23BB-CFFF-44E1-A18F-DAE0E09F3B13Q38816341-D867A859-E49F-42B7-883B-6D2515A2EEB7Q45934043-DBF9E4A3-C13F-4AA0-B34C-4FCA8C972C12Q53806661-0FC1AA32-FD90-4B32-A3C9-BD0ACB452C1D
P2860
Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Development and treatment of t ...... eudohypoparathyroidism type 1B
@ast
Development and treatment of t ...... eudohypoparathyroidism type 1B
@en
type
label
Development and treatment of t ...... eudohypoparathyroidism type 1B
@ast
Development and treatment of t ...... eudohypoparathyroidism type 1B
@en
prefLabel
Development and treatment of t ...... eudohypoparathyroidism type 1B
@ast
Development and treatment of t ...... eudohypoparathyroidism type 1B
@en
P2093
P2860
P356
P1476
Development and treatment of t ...... eudohypoparathyroidism type 1B
@en
P2093
Arnold M Moses
Nicola M Neary
Rachel Hopkins
Steven K Libutti
P2860
P304
P356
10.1210/JC.2012-1655
P407
P577
2012-06-26T00:00:00Z